Lithium Countertransport and Blood Pressure In CARDIA and TOMHS
This study has been completed.
Sponsor:
Information provided by:
National Heart, Lung, and Blood Institute (NHLBI)
ClinicalTrials.gov Identifier:
NCT00005213
First received: May 25, 2000
Last updated: June 23, 2005
Last verified: June 2000
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
To conduct ancillary studies of sodium-stimulated lithium counter-transport in the Chicago components of the Coronary Heart Disease Risk Development in Young Adults (CARDIA) cohort and in the Treatment of Mild Hypertension Study (TOMHS) cohort.
| Condition |
|---|
|
Cardiovascular Diseases Heart Diseases Hypertension |
| Study Type: | Observational |
| Study Design: | Observational Model: Natural History |
Resource links provided by NLM:
Further study details as provided by National Heart, Lung, and Blood Institute (NHLBI):
| Study Start Date: | March 1988 |
| Estimated Study Completion Date: | February 1990 |
Show Detailed Description Eligibility| Genders Eligible for Study: | Male |
| Accepts Healthy Volunteers: | No |
Criteria
No eligibility criteria
Contacts and Locations
No Contacts or Locations Provided
More Information
No publications provided
| ClinicalTrials.gov Identifier: | NCT00005213 History of Changes |
| Other Study ID Numbers: | 1092 |
| Study First Received: | May 25, 2000 |
| Last Updated: | June 23, 2005 |
| Health Authority: | United States: Federal Government |
Additional relevant MeSH terms:
|
Cardiovascular Diseases Heart Diseases Hypertension Vascular Diseases |
ClinicalTrials.gov processed this record on May 19, 2013